Monterey Innovation Acquisition Corp
Cash in trust
$21.9M
$21,865,397
Trust per share
$10.84
Redemption value
IPO
Oct 2021
—
Combination deadline
—
Not disclosed
Filings on record
80
Latest Feb 13, 2024
Overview
Monterey Innovation Acquisition Corp is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001860663. It completed its initial public offering in Oct 2021. The vehicle is sponsored by Monterey Innovation. The mandate targets healthcare. Deadline lapsed without a deal; trust returned to public shareholders.
“we intend to focus our efforts on a biotech company that has demonstrated success and is primed to thrive in the rapidly evolving biotech industry for our initial business combination.”
Reading the filings
Arithmetic on what Monterey Innovation Acquisition Corp has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Trust versus the $10 unit
The trust holds $10.84 per public share, 8.4% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.
Extension history
Shareholders have already approved 2 extensions. Each one opened a redemption window, so the public float and the trust are almost certainly smaller than at IPO, and each typically came with a sponsor contribution that lifts trust per share. A vehicle on its second or third extension is one where the sponsor is paying to keep the search alive.
Warrant coverage
Each unit carried one warrant per unit. Warrants are dilution deferred: they cost the holder nothing until exercised, and they overhang the post-combination share count. Thinner coverage is generally a sign of a stronger book at pricing.
Underwriting
Chardan led the offering. It has been named on 38 SPAC IPOs, book-running 34 of them, and 51.7% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
At every shareholder vote holders may hand their shares back for their cash. Each bar is one vote, read out of the 8-K that reported it.
10M shares handed back across 2 votes, 87% of the shares sold at IPO.
Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.
80 filings in all. 3 in the last three months, against a busiest month of 16.
News on Monterey Innovation Acquisition Corp
Last 90 daysNothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.
SEC filing history
Free tier: filings older than 24 hours- SC 13G/A
FORM SC 13G/A
Accession 0001062993-24-002971
- 15-12G
Deregistration of securities
Accession 0001104659-23-127327
- 8-K
Other events
Item 8.01 · Accession 0001104659-23-122880
- 25-NSE
Notification of delisting
Accession 0001354457-23-000880
- 8-K
Other events
Item 8.01 · Accession 0001104659-23-115289
- 8-K
Notice of delisting or failure to satisfy a listing rule
Item 3.01 · Accession 0001104659-23-109099
- 10-Q
Quarterly report
Accession 0001410578-23-002043
- NT 10-Q
Late quarterly report notification
Accession 0001104659-23-091898
- 8-K
Entry into a material definitive agreement; Submission of matters to a vote of security holders; Other events
Items 1.01, 5.03, 5.07, 8.01, 9.01 · Accession 0001104659-23-079704
- DEFA14A
Additional proxy soliciting material
Accession 0001104659-23-077235
- 8-K
Other events
Item 8.01 · Accession 0001104659-23-077232
- 8-K
Other events
Item 8.01 · Accession 0001104659-23-077088
- DEF 14A
Definitive proxy statement
Accession 0001104659-23-072030
- PRE 14A
PRE 14A
Accession 0001104659-23-067647
- 10-Q
Quarterly report
Accession 0001410578-23-001289
- NT 10-Q
Late quarterly report notification
Accession 0001104659-23-060878
- 10-K
Annual report
Accession 0001410578-23-000670
- 4
Statement of changes in beneficial ownership
Accession 0001104659-23-044191
- 3
Initial statement of beneficial ownership
Accession 0001104659-23-044189
- NT 10-K
Late annual report notification
Accession 0001104659-23-040154
- SC 13D
Beneficial ownership report (activist)
Accession 0001104659-23-036738
- 4
Statement of changes in beneficial ownership
Accession 0001104659-23-031954
- 4
Statement of changes in beneficial ownership
Accession 0001104659-23-031929
- 4
Statement of changes in beneficial ownership
Accession 0001104659-23-031928
- 4
Statement of changes in beneficial ownership
Accession 0001104659-23-031927
- 4
Statement of changes in beneficial ownership
Accession 0001104659-23-031926
- 3
Initial statement of beneficial ownership
Accession 0001104659-23-031925
- 3
Initial statement of beneficial ownership
Accession 0001104659-23-031923
- 3
Initial statement of beneficial ownership
Accession 0001104659-23-031922
- 3
Initial statement of beneficial ownership
Accession 0001104659-23-031920
Pro
Track Monterey Innovation Acquisition Corp without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
Monterey Innovation Acquisition Corp: questions answered
What is Monterey Innovation Acquisition Corp?
Monterey Innovation Acquisition Corp is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001860663. It completed its initial public offering in Oct 2021. The vehicle is sponsored by Monterey Innovation. The mandate targets healthcare. Deadline lapsed without a deal; trust returned to public shareholders.
How much does Monterey Innovation Acquisition Corp hold in trust?
Approximately $21,865,397, or about $10.84 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Monterey Innovation Acquisition Corp complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if Monterey Innovation Acquisition Corp does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Monterey Innovation Acquisition Corp, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.84 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for Monterey Innovation Acquisition Corp?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
How much dilution do Monterey Innovation Acquisition Corp's founder shares and warrants create?
Each unit also carried one warrant per unit, which is dilution deferred until exercise. Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.
Who sponsors Monterey Innovation Acquisition Corp, and what is their track record?
Monterey Innovation is the sponsor entity, part of the Monterey Innovation franchise. This is the only vehicle we have attributed to that sponsor.
Which banks underwrote the Monterey Innovation Acquisition Corp IPO?
Chardan, B. Riley Securities. Chardan was credited as book-running manager on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is Monterey Innovation Acquisition Corp a good investment?
That is not a question this site answers. Monterey Innovation Acquisition Corp is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Monterey Innovation Acquisition Corp data come from?
Filings Monterey Innovation Acquisition Corp submitted to the SEC under CIK 0001860663: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Oct 19, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
Monterey Innovation: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Chardan in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Healthcare SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All liquidated spacs
Deadline lapsed without a deal; trust returned to public shareholders.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.